KLF4 and Hodgkins lymphoma: It is reported that tucidinostat and decitabine showed a synergistic effect to inhibit cell growth of Hodgkin lymphoma through upregulating the expression of tumor suppressor genes PU.1 and Kruppel-like factor 4 (KLF4) (Jiang et al., 2017).